The combination of thymoquinone and paclitaxel shows anti-tumor activity through the interplay with apoptosis network in triple-negative breast cancer Ç Şakalar, K İzgi, B İskender, S Sezen, H Aksu, M Çakır, B Kurt, A Turan, ... Tumor Biology 37, 4467-4477, 2016 | 83 | 2016 |
Fingolimod alters tissue distribution and cytokine production of human and murine innate lymphoid cells A Eken, MF Yetkin, A Vural, M Cakir, O Kilic, H Canatan Frontiers in immunology 10, 429611, 2019 | 37 | 2019 |
Myrtucommulone‐A Induces both Extrinsic and Intrinsic Apoptotic Pathways in Cancer Cells K Izgi, B Iskender, J Jauch, S Sezen, M Cakir, M Charpentier, H Canatan, ... Journal of biochemical and molecular toxicology 29 (9), 432-439, 2015 | 32 | 2015 |
Temporal overexpression of IL‐22 and Reg3γ differentially impacts the severity of experimental autoimmune encephalomyelitis A Eken, S Erdem, Y Haliloglu, F Zehra Okus, M Cakir, M Fatih Yetkin, ... Immunology 164 (1), 73-89, 2021 | 6 | 2021 |
The number and activity of CD3+ TCR Vα7. 2+ CD161+ cells are increased in children with acute rheumatic fever M Ozkaya, A Baykan, M Cakir, C Vural, S Sunkak, E Unal, A Eken International Journal of Cardiology 333, 174-183, 2021 | 4 | 2021 |
Oxidative and chromosomal DNA damage in patients with type I Gaucher disease and carriers R Uzen, F Bayram, H Dursun, F Kardas, P Altın-Celik, M Cakir, A Eken, ... Clinical Biochemistry 111, 26-31, 2023 | 2 | 2023 |
Metformin eliminates CD133high/CD44high prostate cancer stem cells via cell cycle arrest and apoptosis E Acikgoz, M Cakir, M Guven, G Oktem Ejmo 5 (4), 298-304, 2021 | 2 | 2021 |
The Impact of the Gut Microbiome Alterations in Psoriasis S Keskin, M Cakir, E Acikgoz NEW FRONTIERS IN HEALTH SCIENCES, 143, 2023 | 1 | 2023 |
Comparison of peripheral blood th17 cells and associated cytokines in fingolimod-receiving and untreated multiple sclerosis patients Fingolimod alan ve almayan multiple skleroz … A Eken, M YETKİN, F Okus, Ş Erdem, M ÇAKIR, Y Haliloğlu, Z Azizoğlu, ... Turkish Journal of Immunology 7 (2), 2019 | 1 | 2019 |
The effect of alantolactone on the development of multiple sclerosis M Cakir, MO Karayigit, A Eken, H Donmez-Altuntas Multidisciplinary Digital Publishing Institute Proceedings 40 (1), 16, 2019 | 1 | 2019 |
S1P1 Agonist SEW2871 Inhibits human Th17 cell generation and functions A Eken, FZ Okus, MF Yetkin, M Cakir, A Ozdarendeli, M Mirza The Journal of Immunology 198 (1_Supplement), 156.19-156.19, 2017 | 1 | 2017 |
SAT0413 Genetic aspect of inter-individual variability in the response to non-steroidal anti-inflammatory drugs in axial spondyloarthritis G Kilic, C Sakalar, B Kurt, M Cakir, E Kilic, S Ozgocmen Annals of the Rheumatic Diseases 75 (Suppl 2), 819-820, 2016 | 1 | 2016 |
Thymoquinone confers higher cytotoxicity against triple negative breast cancer compared to estrogen receptor positive breast cancer through modulation of TNF receptor … M Cakir, C Sakalar, S Sezen, H Aksu, B Kurt, H Canatan European Journal of Cancer 1 (61), S138-S139, 2016 | 1 | 2016 |
A benzimidazolium salt induces apoptosis and arrests cells at sub-G1 phase in epithelial ovarian cancer cells S Akar, M Cakir, H Ozkol, S Akkoc Molecular Biology Reports 51 (1), 66, 2024 | | 2024 |
Alantolactone ameliorates graft versus host disease in mice GP Odabas, K Aslan, PA Suna, PK Kendirli, Ş Erdem, M Çakır, A Özcan, ... International Immunopharmacology 128, 111560, 2024 | | 2024 |
Investigation of the Effect of Schisandrin B on Cytokine and Chemokine Production in Human Peripheral Blood Cells. Ş Erdem, A Eken, H Altuntaş, M Çakır Gazi Medical Journal 35, 2024 | | 2024 |
Schisandrin B Treatment After Disease Induction Slightly Improved Experimental Autoimmune Encephalomyelitis MF Yetkin, S Erdem, ZB Azizoglu, BS Demir, E Acikgoz, M Cakir, ... MULTIPLE SCLEROSIS JOURNAL 29, 802-803, 2023 | | 2023 |
Characterization of peripheral blood T follicular helper (TFH) cells in patients with type 1 Gaucher disease and carriers R Uzen, F Bayram, H Dursun, F Kardas, M Cakir, N Cucer, A Eken, ... Blood Cells, Molecules, and Diseases 100, 102728, 2023 | | 2023 |
DENEYSEL MULTIPL SKLEROZ (MS) FARE MODELİNDE SCHİSANDRİN B VE ALANTOLAKTON'UN İMMÜNOMODÜLATÖR ETKİLERİNİN ARAŞTIRILMASI. M ÇAKIR Journal of Health Sciences/Erciyes Üniversitesi Saglik Bilimleri Dergisi 29 (3), 2020 | | 2020 |
Schisandrin B and Alantolactone ameliorates experimental autoimmune encephalomyelitis in mice A Eken, M Cakir, MO Karayigit, HD Altuntas The Journal of Immunology 204 (1_Supplement), 160.12-160.12, 2020 | | 2020 |